Joel J Davis
Affiliation: San Diego State University
- Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugsJ J Davis
School of Communication, San Diego State University, San Diego, CA 92182 4561, USA
J Health Commun 5:349-69. 2000..Implications of the research for the regulation and presentation of DTC prescription drug advertising and advertiser communication practices are discussed...
- Disenfranchising the disabled: the inaccessibility of Internet-based health informationJoel J Davis
School of Communication, San Diego State University, California 92182 4516, USA
J Health Commun 7:355-67. 2002..Analyses of reasons why home pages were inaccessible indicate that accessibility could be improved if recommended design and coding changes are implemented...
- Pharmaceutical websites and the communication of risk informationJoel J Davis
School of Communication, San Diego State University, San Diego, California 92182, USA
J Health Commun 12:29-39. 2007..For drugs with side effects at >or= 10% incidence, only about half of their websites fully reported all effects at this level of incidence. Implications for advertisers and regulatory agencies are presented...
- Consumers' preferences for the communication of risk information in drug advertisingJoel J Davis
San Diego State University, San Diego, California, USA
Health Aff (Millwood) 26:863-70. 2007..Consumers prefer detailed, readily accessible risk information--preferences that are a major departure from current advertiser practices and from what current and proposed Food and Drug Administration (FDA) regulations require...
- The effect of qualifying language on perceptions of drug appeal, drug experience, and estimates of side-effect incidence in DTC advertisingJoel Davis
School of Journalism and Media Studies, San Diego State University, San Diego, California 92182 4561, USA
J Health Commun 12:607-22. 2007..Policy implications of the research, particularly for evaluation of "fair balance" and the reporting of side effects, are presented...